Status:
UNKNOWN
Evaluate Efficacy, Tolerability & Safety of Combination of Clindamycin and Ketoconazole for the Treatment of Mixed-Type Vaginosis, Bacterial Vaginosis and Candidiasis
Lead Sponsor:
Zodiac Produtos Farmaceuticos S.A.
Conditions:
Candidiasis
Bacterial Vaginosis
Eligibility:
FEMALE
18-50 years
Phase:
PHASE3
Brief Summary
The purpose of this study is to determine the Efficacy, Tolerability \& Safety of Combination of Clindamycin 100mg and Ketoconazole 400mg in Vaginal Capsules, used for 7 consecutive days in patients w...
Eligibility Criteria
Inclusion
- Mixed-type vaginosis
- Bacterial vaginosis
- Candidiasis
Exclusion
- Pregnancy
- Vaginal bleeding
- History of recurrent vaginosis
Key Trial Info
Start Date :
September 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 1 2010
Estimated Enrollment :
160 Patients enrolled
Trial Details
Trial ID
NCT00889356
Start Date
September 1 2009
End Date
March 1 2010
Last Update
April 28 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Vox Femina
Jundiaí, São Paulo, Brazil